New Palo Alto Clinic Combines AI Technology with Neurological Expertise to Deliver Same-Day Initial Results, Eliminating Weeks-Long Wait Times

Neuvera Brain Health Institute Opens New Brain Disorder Diagnostic

PALO ALTO, CA – January 30, 2026 – Neuvera Brain Health Institute today announced the scheduled grand opening in February 2026 of its new EEG diagnostic facility in Palo Alto, introducing the Bay Area’s first “brain health clinic” model.

Neuvera will be delivering a same-day brain health assessment for anybody interested in checking the status of their own brain health, in consultation with the in-house physician. For patients, 1) a same-day EEG recordings and results with AI-assisted preliminary reports available within minutes, followed by comprehensive neurologist interpretation. This will include routine EEG and long-term EEG monitoring, 2)TMS treatments for depression, OCD and Migraine and 3) consulting for patients who have been struggling to get accurate diagnosis.
Founded by a Stanford PhD and Professor, Dr. Jin Hyung Lee and led by Medical Director Dr. Joshuae Gallardo, Neuvera addresses a critical gap in neurological care by easy access, same-week appointments that bypass traditional neurologist waitlists, which can extend for weeks.
“Many patients with neurological symptoms face weeks or months of uncertainty while waiting for EEG appointments,” said Jin Hyung Lee, Founder of Neuvera Brain Health Institute. “We saw an opportunity to address this care gap by streamlining the diagnostic process, combining AI efficiency with expert medical oversight to provide answers for those in need.”

Advanced AI Technology Meets Expert Medical Oversight
Neuvera’s diagnostic capabilities are powered by the FDA-cleared LVIS NeuroMatch EEG Software Platform, which combines artificial intelligence with board-certified neurologist interpretation. The system’s advanced AI continuously scans EEG recordings enabling neurologists to detect previously hard to identify events, e.g. detecting subtle epileptiform and non-epileptiform events that might be missed by traditional analysis methods.

“Every AI-assisted result is confirmed and interpreted by our team of board-certified neurologists and epileptologists,” explained Dr. Joshuae Gallardo, Medical Director. “This hybrid approach ensures patients receive both the speed and accuracy of AI detection and the expertise of human medical interpretation.”
The cloud-based platform provides secure, HIPAA-compliant access for both patients and referring physicians, with preliminary analysis available within minutes of study completion and full neurologist reports delivered promptly.

Preventative Brain Health
Beyond urgent diagnostic needs, Neuvera introduces the Baseline Neuro Metrics program, establishing personalized brain activity profiles for patients. This preventative approach enables longitudinal tracking to detect subtle neurological changes over time before symptoms manifest.
“We’re focused on providing proactive neurological care rather than just reactive treatment,” said Lee. “By establishing each patient’s unique brain health baseline, we can monitor inter study changes and provide data-driven insights to clinicians for long-term brain health management of their patients.”

Patient-Centered Experience
The Palo Alto facility features a modern, tech-first environment designed to feel more like a wellness center than a traditional medical facility. The clinic provides streamlined EEG (brainwave recording) procedures and online appointment scheduling. Online reports and longitudinal study review tools assist referring physicians in examining interstudy measures.
Located at 2600 East Bayshore Road, Suite 100, the clinic provides convenient access with reserved on-site parking and proximity to both Highway 101 and the Palo Alto Caltrain station.

Expanding Nationwide Access
Neuvera Palo Alto represents the first United States location in a planned nationwide expansion. Global operations are located in Seoul and Daegu, South Korea with expansion efforts planned throughout the Asia Pacific, Europe, and Middle East regions. The company’s scalable model utilizes remote reading capabilities through the central NeuroMatch platform, enabling consistent, high-quality care across multiple locations without requiring in-house neurologists at each facility.

“Our standardized, technology-driven approach allows us to bring exceptional brain health access to communities in need.” said Lee. “We’re building a network that makes rapid, expert neurological care available wherever patients need it.”

Addressing Critical Healthcare Gaps
The new facility directly addresses significant challenges in current neurological care:
– Hospital limitations: Slow scheduling, high costs, and cumbersome processes
– Traditional neurology offices: Extended wait times and complex billing
– Neuvera solution: Fast, affordable, tech-driven, patient-centric care

Services include complete patient preparation by credentialed EEG technologists, acquisition using industry-leading hardware and software, non-invasive neuromodulation therapy, and comprehensive support from scheduling through immediate physician access to recorded data. Procedures can be completed in the office or in the home. The facility will accept most major insurance plans.
About Neuvera Brain Health Institute

Neuvera Brain Health Institute is a neurological and psychiatric diagnostic and therapeutic center focused on reducing wait times for brain health answers. Founded by Stanford PhD and Professor Dr. Jin Hyung Lee and led by Medical Director Dr. Joshuae Gallardo, M.D., Neuvera combines FDA-cleared AI technology with expert medical interpretation to provide same-day initial results and preventative brain health monitoring.

For more information, visit www.neuvera.org.
Location: 2600 East Bayshore Road, Suite 100, Palo Alto, CA 94303

Media Contact:
Email: contact@neuvera.org
Phone: 650-681-8759
Neuvera Brain Health Institute